1. Home
  2. ACU vs SPRO Comparison

ACU vs SPRO Comparison

Compare ACU & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

N/A

Current Price

$40.58

Market Cap

154.0M

ML Signal

N/A

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.29

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
SPRO
Founded
1867
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
136.7M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ACU
SPRO
Price
$40.58
$2.29
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
8.1K
280.4K
Earning Date
10-21-2025
11-13-2025
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
$40,549,000.00
Revenue This Year
$2.19
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$16.56
N/A
Revenue Growth
2.35
N/A
52 Week Low
$34.35
$0.51
52 Week High
$45.25
$3.22

Technical Indicators

Market Signals
Indicator
ACU
SPRO
Relative Strength Index (RSI) 62.38 47.60
Support Level $40.78 $2.26
Resistance Level $42.33 $2.42
Average True Range (ATR) 1.37 0.08
MACD 0.22 0.00
Stochastic Oscillator 78.40 27.15

Price Performance

Historical Comparison
ACU
SPRO

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: